Clinical Trials Logo

Clinical Trial Summary

a phase I trial focusing on safety and efficacy of prednison shock plus sirolimus maintenance in treating Kaposiform hemangioendothelioma (KHE) with Kasabach-Merritt phenomenon (KMP)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04409691
Study type Interventional
Source Shanghai Children's Medical Center
Contact Song Gu
Phone 18930830716
Email gusong@shsmu.edu.cn
Status Not yet recruiting
Phase Phase 1
Start date July 1, 2020
Completion date June 30, 2023